Parkin gene alterations in ovarian carcinoma from northern Indian population

Pathology and Oncology Research

Volumn 17, Issue 3, 2011, Pages 579-586

  Mehdi, Syed Jafar ^a   Ali, Asgar ^a   Rizvi, M Moshahid Alam ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Loss of heterozygosity; Ovarian cancer; Parkin gene; Reverse transcriptase PCR; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; PARKIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHROMOSOME 6; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; EPIGENETICS; EXON; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; OVARY CARCINOMA; PARKIN GENE; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; CYSTADENOCARCINOMA, SEROUS; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INDIA; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; UBIQUITIN-PROTEIN LIGASES;

EID: 80052730894     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9351-x     Document Type: Article

References (40)

1. SH Landis T Murray S Bolden PA Wingo 1998 Cancer statistics, 1998 Cancer J Clin 48 6 29 10.3322/canjclin.48.1.6 1:STN:280:DyaK1c7htFGrtg%3D%3D (Pubitemid 28045531)
2. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics, 2008 CA Cancer J Clin 58 2 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
3. Boyle P, Levin B (2008) International Agency for Research on Cancer, and World Health Organization, "World cancer report 2008." Distributed by WHO Press, Geneva, Switzerland
4. American Cancer Society. Facts & Figures 2009
5. GLOBOCAN (2008) Cancer incidence, mortality and prevalence worldwide. IARC 2008. IARC, Lyon
6. M Theile S Seitz W Arnold B Jandrig R Frege PM Schlag W Haensch H Guski KJ Winzer JC Barrett S Scherneck 1996 A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer Oncogene 13 677 685 8761288 1:CAS:528:DyaK28Xlt1yit7g%3D (Pubitemid 26312894)
7. BC Bastian PE LeBoit H Hamm EB Brocker D Pinkel 1998 Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization Cancer Res 58 2170 2175 9605762 1:CAS:528:DyaK1cXjt12ht78%3D (Pubitemid 28232904)
8. D Reutzel M Mende S Naumann S Störkel W Brenner B Zabel J Decker 2001 Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization Cytogenet Cell Genet 93 221 227 11528115 10.1159/000056987 1:CAS:528:DC%2BD3MXntVKiu7c%3D (Pubitemid 32799807)
9. C Jin C Martins Y Jin J Wiegant J Wennerberg M Dictor D Gisselsson B Strömbeck I Fonseca F Mitelman HJ Tanke M Hoglund F Mertens 2001 Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH Genes Chromosome Cancer 30 161 167 10.1002/1098-2264(2000)9999:9999<::AID-GCC1077>3.0.CO;2-B 1:CAS:528:DC%2BD3MXnsFyhsQ%3D%3D (Pubitemid 32044596)
10. A Jackson P Carrara V Duke P Sinclair M Papaioannou CJ Harrison L Foroni 2000 Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis Cancer Res 60 2775 2779 10850412 1:CAS:528:DC%2BD3cXjvFOls7Y%3D (Pubitemid 30395790)
11. B Carvalho AY Veen F Gärtner F Carneiro R Seruca CHCM Buys K Kok 2001 Allelic gains and losses in distinct regions of chromosome 6 in gastric carcinoma Cancer Genet Cytogenet 131 1 54 59 11734319 10.1016/S0165-4608(01) 00514-3 1:CAS:528:DC%2BD3MXovVCjs78%3D (Pubitemid 33081158)
12. AT De Souza GR Hankins MK Washington RL Fine TC Orton RL Jirtle 1995 Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors Oncogene 10 9 1725 1729 7753549
13. A Merlo E Gabrielson M Mabry R Vollmer SB Baylin D Sidransky 1994 Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer Cancer Res 54 2322 2326 8162574 1:CAS:528:DyaK2cXjt1Sgur4%3D (Pubitemid 24138718)
14. T Visakorpi AH Kallioniemi AC Syvänen ER Hyytinen R Karhu T Tammela JJ Isola OP Kallioniemi 1995 Genetic changes in primary reccurent prostate cancer by comparative genomic hybridization Cancer Res 55 342 347 7529134 1:CAS:528:DyaK2MXjtFyjsbw%3D
15. H Tahara AP Smith RD Gaz VL Cryns A Arnold 1996 Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas Cancer Res 56 599 605 8564978 1:CAS:528:DyaK28XnslOhsw%3D%3D (Pubitemid 26043660)
16. L Sebsebe P Lea S Markku N Mika S Sirkku HP Kirsti B Tom 2004 Loss of Heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas J Neuropathol Exp Neurol 63 10 1072 1079
17. M Inoue A Marx A Zettl P Ströbel HK Müller-Hermelink P Starostik 2002 Chromosome 6 suffers frequent and multiple aberrations in thymoma Am J Pathol 161 4 1507 1513 12368223 10.1016/S0002-9440(10)64426-4 1:CAS:528:DC%2BD38Xotl2jt7s%3D
18. NN Mazurenko IS Beliakov AY Bliyev Z Guo X Hu SV Vinokourova BA Bidzhieva LS Pavlova J Ponten FL Kisseljov 2003 Genetic alterations at chromosome 6 associated with cervical cancer progression Mol Biol 37 3 404 411 10.1023/A:1024287327107 1:CAS:528:DC%2BD3sXks1Cgtbk%3D
19. M Wan T Sun R Vyas J Zheng E Granada L Dubeau 1999 Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25 Oncogene 18 1545 1551 10102624 10.1038/sj.onc.1202476 1:CAS:528:DyaK1MXhvVyls7Y%3D (Pubitemid 29108054)
20. ZM Sheng A Marchetti F Buttitta MH Champeme D Campani M Bistocchi R Lidereau R Callahan 1996 Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas Br J Cancer 73 144 147 8546898 10.1038/bjc.1996.27 1:CAS:528:DyaK28XhsVSisb8%3D (Pubitemid 26028326)
21. CV Colitti KJ Rodabaugh WR Welch RS Berkowitz SC Mok 1998 A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinoma Oncogene 16 555 559 9484846 10.1038/sj.onc.1201523 1:CAS:528:DyaK1cXhtVansbg%3D (Pubitemid 28062084)
22. MG Tibiletti B Bernasconi D Furlan C Riva M Trubia G Buraggi M Franchi P Bolis A Mariani L Frigerio C Capella R Taramelli 1996 Early involvement of 6q in surface epithelial ovarian tumors Cancer Res 56 4493 4498 8813146 1:CAS:528:DyaK28XmtVyltb8%3D (Pubitemid 26330460)
23. IE Cooke AN Shelling VG Le Meuth ML Charnock TS Ganesan 1996 Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer Genes Chromosom Cancer 15 223 233 8703848 10.1002/(SICI)1098- 2264(199604)15:4<223::AID-GCC4>3.0.CO;2-3 1:CAS:528:DyaK28Xis1Onu74%3D (Pubitemid 26115930)
24. MG Tibiletti M Trubia E Ponti L Sessa F Acquati D Furlan B Bernasconi M Fichera A Mihalich A Ziegler A Volz C Facco 1998 Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involvement in benign surface epithelial ovarian tumours Oncogene 16 1639 1642 9569033 10.1038/sj.onc.1201654 1:CAS:528:DyaK1cXis1eju7Y%3D (Pubitemid 28159913)
25. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura S Minoshima M Yokochi Y Mizuno N Shimizu 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature (Lond) 392 605 608 10.1038/33416 1:CAS:528:DyaK1cXis1Sqsrc%3D (Pubitemid 28207717)
26. R Cesari ES Martin GA Calin F Pentimalli R Bichi H McAdams F Trapasso A Drusco M Shimizu V Masciullo G d'Andrilli G Scambia MC Picchio H Alder AK Godwin CM Croce 2003 Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 Proc Natl Acad Sci USA 100 5956 5961 12719539 10.1073/pnas.0931262100 1:CAS:528:DC%2BD3sXjvFOltrY%3D (Pubitemid 36581860)
27. SR Denison G Callahan NA Becker LA Phillips DI Smith 2003 Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer Genes Chromosom Cancer 38 40 52 12874785 10.1002/gcc.10236 1:CAS:528:DC%2BD3sXntVygtbc%3D (Pubitemid 36994883)
28. A West M Periquet S Lincoln CB Lucking D Nicholl V Bonifati N Rawal T Gasser E Lohmann J Hardy A Brice M Farrer 2002 Complex relationship between Parkin mutations and Parkinson disease Am J Med Genet 114 584 591 12116199 10.1002/ajmg.10525 (Pubitemid 34680590)
29. MC Picchio ES Martin R Cesari GA Calin S Yendamuri T Kuroki F Pentimalli M Sarti K Yoder LR Kaiser R Fishel CM Croce 2004 Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer Clin Cancer Res 10 2720 2724 15102676 10.1158/1078-0432.CCR-03-0086 1:CAS:528:DC%2BD2cXjt1CltLs%3D (Pubitemid 38509147)
30. Mehdi SJ, Alam MS, Batra S, Rizvi MMA (2010) Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma. Medical Oncology (in press). doi: 10.1007/s/12032-010-9633-x
31. SR Denison F Wang NA Becker B Schüle N Kock LA Phillips C Klein DI Smith 2003 Genetic alteration in the common fragile site gene PARK2 in ovarian and other cancers Oncogene 22 8370 8378 14614460 10.1038/sj.onc.1207072 1:CAS:528:DC%2BD3sXovVyms7s%3D (Pubitemid 37485529)
32. F Wang S Denison JP Lai LA Philips D Montoya N Kock B Schüle C Klein V Shridhar LR Roberts DI Smith 2004 Parkin gene alterations in hepatocellular carcinoma Genes Chromosom Cancer 40 85 96 15101042 10.1002/gcc.20020 1:CAS:528:DC%2BD2cXks1yhurw%3D (Pubitemid 38579877)
33. S Veeriah BS Taylor S Meng F Fang E Yilmaz I Vivanco M Janakiraman N Schultz AJ Hanrahan W Pao M Ladanyi C Sander A Heguy EC Holland PB Paty PS Mischel L Liau TF Cloughesy IK Mellinghoff DB Solit TA Chan 2010 Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies Nat Genet 42 1 77 82 19946270 10.1038/ng.491 1:CAS:528:DC%2BD1MXhsVylsb%2FN
34. JL Benedet H Bender H Jones III HYS Ngan S Pecorelli 2000 FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers Int J Gynecol Obstet 70 209 262 10.1016/S0020-7292(00)90001- 8 1:STN:280:DC%2BD3cvpsFegtQ%3D%3D
35. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Lab, Plainview
36. X Yuping M Lili H Chengbo L Jinyi X Lei X Yan 2007 MSI/LOH and extron expression of the FHIT gene in gastric carcinoma Front Med China 1 1 99 103 10.1007/s11684-007-0019-1
37. Preacher KJ (2001) Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software]. Available from http://www.quantpsy.org
38. WD Foulkes J Ragoussis GWH Stamp GJ Allan J Trowsdale 1993 Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma Br J Cancer 67 551 559 8094976 10.1038/bjc.1993.101 1:STN:280:DyaK3s7ns1KqtQ%3D%3D (Pubitemid 23077651)
39. MZT Wan G D'Abling I Zheng M Veliscu L Dubeau 1994 Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas J Oncol 5 1043 1048 1:CAS:528:DyaK2cXmvFyisrc%3D (Pubitemid 24318732)
40. X Agirre J Román-Gómez I Vázquez A Jiménez-Velasco L Garate C Montiel-Duarte P Artieda L Cordeu I Lahortiga MJ Calasanz A Heiniger A Torres JD Minna F Prósper 2006 Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia Int J Cancer 118 1945 1953 16287063 10.1002/ijc.21584 1:CAS:528:DC%2BD28Xjt1Gqtbc%3D